12080 J. Am. Chem. Soc., Vol. 119, No. 50, 1997
Berti et al.
Amersham Life Sciences (Arlington Heights, IL). Except for 18O-
labeled NAD+, isotopically labeled NAD+’s were synthesized as in
Rising and Schramm.31
18O-NAD+’s. [5-18O]Glucose. Labeled glucose was synthesized
from the ketone precursor (the generous gift of Michael Sinnott of
University of Illinois at Chicago) similarly to the method described
previously,32 except that the material was not recrystallized after LiAlH4
reduction. [5-18O]glucose was purified by sequential phosphorylation
with hexokinase, anion-exchange chromatography, dephosphorylation
with glucose 6-phosphatase, and repurification under the same condi-
tions. Hexokinase and glucose 6-phosphatase were dialyzed against
50 mM potassium phosphate (pH 7.5) before use to remove unlabeled
glucose. [5-18O]Glucose (55 µmol in 2 mL) was phosphorylated to
glucose 6-phosphate with 2 u of hexokinase, 60 mM ATP, and 60 mM
MgCl2 in 50 mM potassium phosphate (pH 7.5) for 2 h at room
temperature. The reaction mixture was reduced to approximately half-
volume under vacuum, applied to a 10 mL column of DEAE-Sephadex
A-25 which had been equilibrated with H2O, then washed with 10 ×
1 mL of H2O. [5-18O]Glucose 6-phosphate was eluted with 10 × 1
mL of 1 M NH4OAc. The fractions containing product were identified
using the reducing sugar assay,33 pooled, frozen, and lyophilized twice.
The [5-18O]glucose 6-phosphate was dephosphorlyated with 0.1 u of
glucose 6-phosphatase in 50 mM potassium phosphate (pH 7.5) for 2
h at room temperature. Anion exchange chromatography was per-
formed as above, with [5-18O]glucose eluting in the H2O fractions.
18O-NAD+. [4′-18O]NAD+ and [4′N-18O,8A-14C]NAD+ 34 were syn-
thesized as described previously,31 with several modifications. The
synthesis of nicotinic acid adenine dinucleotide (NaAD+) was done in
two steps to allow incorporation of the 14C-label from [8-14C]ATP. In
the first step, nicotinic acid mononucleotide (NaMN+) was synthe-
sized,31 except that hexokinase, glucose 6-phosphate dehydrogenase,
6-phosphogluconate dehydrogenase, and phosphoriboisomerase were
combined and dialyzed against 50 mM potassium phosphate (pH 7.5)
to minimize addition of unlabeled intermediates from the enzyme
preparations. The NH3 needed for the glutamate dehydrogenase reaction
is normally supplied from the above enzyme preparations, which are
(NH4)2SO4 suspensions; in this reaction, NH3HCO3 was added to 1.5
mM. After 9 h, the reaction was heated at 100 °C for 2 min to stop
the enzyme reactions. Fructose (2 mM), 0.2 u of hexokinase, and 4 u
of myokinase were added to convert ATP to AMP. NaMN+ was
isolated by C18 reverse phase HPLC chromatography on a 7.8 × 300
mm column in 50 mM NH4OAc (pH 5.0) then lyophilized. NaAD+
was synthesized in two parallel reactions. To the lyophilized NaMN+
was added 1 mL of 4 mM ATP, 4 mM MgCl2, 50 mM KCl, 50 mM
potassium phosphate (pH 7.5), and 0.25 u of NAD+ pyrophosphorylase,
plus 10 µCi of [8-14C]ATP in one reaction mixture. The reactions were
followed by HPLC for 15 h. The product NaAD+ was purified, and
NAD+ was synthesized as described previously.31 Starting with water
with an 18O content of 60% to make labeled glucose, the [4′-18O]NAD+
contained 37.1% 18O-label, as determined by mass spectrometry (see
below). 4′-18O KIEs measured by the radiolabel technique were
corrected for the extent of 18O-labeling.
Figure 1. NAD+ molecule with positions of isotopic labels (3H, 14C,
15N, 18O) in bold type.
for treating bacterial disease, inhibitors of enzymes that cleave
N-ribosidic bonds (e.g., diphtheria,17,18 pseudomonas exotoxin,19
ricin,20 and gelonin21 ) have the potential to be used with
immunotoxins in the treatment of cancer, to rescue normal cells
from nonspecific killing by the immunotoxins.22,23 Enzymes
catalyzing other ADP-ribosylation reactions of great biological
interest have recently been described, such as poly(ADP-ribose)
synthase, involved in DNA repair,24 and cyclic-ADP-ribose
synthase,25 involved in intracellular signaling, plus other mono-
ADP-ribosyl transferases.26 Determination of the transition state
structures for diphtheria toxin-catalyzed reactions will be
applicable to other biologically important systems.
In the absence of its physiological target, diphtheria toxin,
like cholera and pertussis toxins, catalyzes a slow hydrolysis
of NAD+ to ADP-ribose and nicotinamide.27 Although the
reaction has no physiological significance, it can be exploited
to measure the kinetic isotope effects (KIEs) of labeled NAD+
substrates (Figure 1). From KIEs determined at many labeled
positions in the NAD+ molecule, it is possible to determine the
transition state structure of the reaction using bond-energy/bond-
order vibrational analysis. Knowing the transition state structure
will permit further characterization of the mechanisms by which
the enzyme stabilizes the enzymatic transition state complex to
promote catalysis. The structure of the enzyme-stabilized
transition state provides a target structure for the design of
transition state analogues as inhibitors. Transition state analyses
of NAD+ hydrolysis catalyzed by cholera28 and pertussis29 toxins
have been reported. In the accompanying article,30 the transition
state structure of solvolytic hydrolysis of NAD+ is reported and
a new, structure interpolation method of transition state structure
determination is described.
Materials and Methods
Materials. Hexokinase, myokinase, and glucose 6-phosphatase were
from Sigma Chemical Co. (St. Louis, MO); [8-14C]ATP was from
(17) Li, B. Y. R. S. J. Biol. Chem. 1994, 269, 2652-2658.
(18) Murphy, J. R.; vanderSpek, J. C. Sem. Cancer Biol. 1995, 6, 259-
267.
Recombinant Diphtheria Toxin A-Chain (DTA). Recombinant
DNA Procedures. An entirely synthetic gene encoding the catalytic
domain of diphtheria toxin was used for expression of protein (S.R.B.
and R. J. Collier, unpublished results). The synthetic gene was designed
by altering the codon usage of the corynephage â-gene to reflect the
bias exhibited by highly expressed proteins in Escherichia coli. The
gene was divided into smaller, evenly spaced fragments by engineering
unique restriction sites throughout the open reading frame. The DTA
synthetic gene was cloned into pET-15b (Novagen, Inc.), replacing the
NcoI-BamHI fragment, and transformed into the E. coli strain BL21
(DE3a) for expression of the proteins under transcriptional control of
the T-7 promoter.
(19) Kreitman, R. J.; Pastan, I. Sem. Cancer Biol. 1995, 6, 297-306.
(20) Roy, D. C.; Ouellet, S.; Le Houillier, C.; Ariniello, P. D.; Perreault,
C.; Lambert, J. M. J. Nat. Cancer Inst. 1996, 88, 1136-1145.
(21) French, R. R.; Penney, C. A.; Browning, A. C.; Stirpe, F.; George,
A. J.; Glennie, M. J. Br. J. Cancer 1995, 71, 986-994.
(22) Gould, B. J.; Borowitz, M. J.; Groves, E. S.; Carter, P. W.; Anthony,
D.; Weiner, L. M.; Frankel, A. E. J. Nat. Cancer Inst. 1989, 81, 775-781.
(23) Pai, L. H.; Pastan, I. In Biologic Therapy of Cancer, 2nd ed.; DeVita,
V. T., Jr., Hellman, S., Rosenberg, S. A., Eds.; Lippincott: Philadelphia,
PA, 1995; pp 521-533.
(24) Sugimura, T.; Miwa, M. Mol. Cell. Biochem. 1994, 138, 5-12.
(25) Lee, H. C.; Galione, A.; Walseth, T. F. Vitam. Horm. 1994, 48,
199-257.
(26) See: ADP-ribosylation reactions; Poirier, G. G., Moreau, P., Eds.;
Springer-Verlag: New York, 1992.
Fermentation and Harvest of E. coli. A 50 mL culture of L-broth
(100 µg/mL ampicillin) was inoculated with a single colony from an
(27) Kandel, J.; Collier, R. J.; Chung, D. W. J. Biol. Chem. 1974, 249,
2088-2097.
(31) Rising, K. A.; Schramm, V. L. J. Am. Chem. Soc. 1994, 116, 6531-
6536.
(32) Bennet, A. J.; Sinnott, M. L. J. Am. Chem. Soc. 1986, 108, 7287-
7294.
(33) Parkin, D. W.; Horenstein, B. A.; Abdulah, D. R.; Estupinan, B.;
Schramm, V. L. J. Biol. Chem. 1991, 266, 20658-20665.
(28) Rising, K. A.; Schramm, V. L. J. Am. Chem. Soc. 1997, 119, 27-
37.
(29) Scheuring, J.; Schramm, V. L. Biochemistry 1997, 36, 4526-4534.
(30) Berti, P. J.; Schramm, V. L. J. Am. Chem. Soc. 1997, 119, 12069-
12078.